Deep dive

Building Intelligent pharmacovigilance systems

With rapid advances in intelligent technology and other solutions, how may we best harness this momentum to ensure pharmacovigilance stands to benefit too?

Inspired by the talks hosted by the Uppsala Monitoring Centre at the 23rd ISoP annual meeting, the following articles serve as further reading for those wanting to know more about how we can advance pharmacovigilance practice in areas such as medication errors, signal detection, and protecting patients against side-effects.

Making fewer medication errors – Education and training remain key

Medication errors significantly contribute to the global number of ADRs per year. How may we best prepare the pharmacovigilance community to tackle the problem?

02 April 2024

To genotype or not to genotype, that is the question

Our genes contribute anything from 15 to 95% of how we react to medicines. Why is this the case, and how might genetic testing help avoid the risk of potential side effects?

21 August 2024

Artificial intelligence in pharmacovigilance: Harnessing potential, navigating risks

AI holds potential to transform pharmacovigilance. But navigating the risks requires critical assessment. This article explores AI's evolving role in medicines safety.

22 October 2024

Weeding out duplicates to better detect side-effects

Duplicate reports are a big problem when it comes to signal detection, but with the help of machine learning and new ways of comparing reports, we may more effectively detect them.

25 April 2024

Ecopharmacovigilance: Ensuring environmental safety from pharmaceuticals

Pharmacovigilance monitors the safety of the medicines we use, but what about those that get into our environment?

15 October 2024